Physician profile
Zaheed Tai
NPI 1487611299
$122,856.97
in general payments reported to CMS, 2019-2025
34 companies · $5,113 in 2025
The $5,113 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $13K · 2021: $38K · 2022: $18K · 2023: $13K · 2024: $12K · 2025: $5,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,500 · Honoraria: $4,550 · Food and Beverage: $3,614 · Gift: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $15,733.33 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,500.00 |
| Honoraria | $4,550.00 |
| Food and Beverage | $3,614.47 |
| Gift | $108.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $69,128.15 | 2019-2025 | Impella |
| Boston Scientific Corporation | $21,347.18 | 2019-2025 | Mamba, Crossboss, Avvigo Guidance System |
| Angiodynamics, INC. | $20,056.27 | 2020-2025 | Auryon Laser System 100-120 Vac |
| Philips North America LLC | $6,039.16 | 2019 | |
| Medtronic Vascular, INC. | $1,655.11 | 2019-2020 | |
| Penumbra, INC. | $962.11 | 2019-2025 | Penumbra System, Indigo System |
| Cardiovascular Systems INC. | $869.63 | 2019-2023 | Diamondback Peripheral, Diamondback Coronary |
| Shockwave Medical, INC | $678.26 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $357.22 | 2021-2025 | Diamondback Coronary, Optis, Dragonfly Opstar |
| Medtronic, INC. | $332.63 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Reveal Linq |
| Edwards Lifesciences Corporation | $167.09 | 2019-2023 | Sapien 3 Ultra Resilia |
| W. L. Gore & Associates, INC. | $156.80 | 2019 | |
| Teleflex LLC | $123.92 | 2020-2023 | Turnpike |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.77 | 2019-2022 | |
| Celonova Biosciences, INC. | $100.00 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $88.56 | 2020-2025 | Rotarexs 6 F X 135 Cm |
| Merck Sharp & Dohme LLC | $88.26 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $81.75 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $79.68 | 2020-2024 | Farxiga |
| Amgen INC. | $71.42 | 2019-2022 | |
| Inari Medical, INC. | $65.25 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Recor Medical INC | $63.39 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.14 | 2021-2022 | |
| Reflow Medical INC | $46.84 | 2024-2025 | |
| Acist Medical Systems, INC. | $28.18 | 2022 | |
| Cardiva Medical, INC. | $19.49 | 2024 | Savvywire |
| Surmodics, INC. | $18.08 | 2022 | |
| Silk Road Medical, INC. | $14.12 | 2021 | |
| Cordis US Corp. | $13.77 | 2024 | S.M.A.R.T. |
| Kestra Medical Technology Services, INC. | $13.61 | 2025 | Assure Wcd |
| Biosense Webster, INC. | $11.89 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.24 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$413,252.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zaheed Tai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.